- Report
- October 2020
- 174 Pages
Asia Pacific
From €2007EUR$2,100USD£1,708GBP
€2867EUR$3,000USD£2,439GBP
- Report
- October 2020
- 164 Pages
Middle East, Africa
From €2007EUR$2,100USD£1,708GBP
€2867EUR$3,000USD£2,439GBP
- Report
- October 2020
- 177 Pages
Europe
From €2007EUR$2,100USD£1,708GBP
€2867EUR$3,000USD£2,439GBP
- Report
- September 2020
- 179 Pages
Global
From €3044EUR$3,185USD£2,590GBP
€4348EUR$4,550USD£3,700GBP
- Report
- January 2022
- 90 Pages
North America
From €4539EUR$4,750USD£3,862GBP
- Report
- January 2022
- 90 Pages
Europe
From €4539EUR$4,750USD£3,862GBP
- Report
- August 2020
- 90 Pages
Africa
From €3584EUR$3,750USD£3,049GBP
- Report
- August 2020
- 70 Pages
Asia Pacific
From €3584EUR$3,750USD£3,049GBP
- Report
- April 2023
- 500 Pages
Global
From €3584EUR$3,750USD£3,049GBP
- Report
- April 2020
- 150 Pages
Global
From €6642EUR$6,950USD£5,651GBP
- Report
- February 2020
- 94 Pages
Global
From €2389EUR$2,500USD£2,033GBP
- Report
- October 2023
- 90 Pages
India
From €3345EUR$3,500USD£2,846GBP
- Report
- July 2021
- 284 Pages
Global
From €4683EUR$4,900USD£3,984GBP
- Report
- January 2023
- 132 Pages
Global
From €4253EUR$4,450USD£3,618GBP
- Report
- April 2022
- 135 Pages
Global
From €4253EUR$4,450USD£3,618GBP
- Report
- January 2019
- 105 Pages
Global
From €4109EUR$4,300USD£3,496GBP
- Report
- June 2021
- 32 Pages
Global
€21024EUR$22,000USD£17,889GBP
- Drug Pipelines
- January 2018
- 13 Pages
Global
From €9556EUR$10,000USD£8,131GBP
- Drug Pipelines
- January 2018
- 16 Pages
Global
From €9556EUR$10,000USD£8,131GBP
- Report
- August 2022
- 109 Pages
Global
From €3775EUR$3,950USD£3,212GBP
The Cancer Vaccines market is a rapidly growing sector of the healthcare industry. It is focused on the development of vaccines to prevent and treat cancer. These vaccines are designed to stimulate the body's immune system to recognize and attack cancer cells. The goal is to reduce the risk of cancer recurrence and improve the quality of life for cancer patients.
The Cancer Vaccines market is composed of a variety of companies, ranging from large pharmaceutical companies to small biotechnology firms. These companies are involved in the research, development, and production of cancer vaccines. They are also involved in clinical trials to test the safety and efficacy of these vaccines.
Some of the major players in the Cancer Vaccines market include Merck, GlaxoSmithKline, Pfizer, Sanofi, and Johnson & Johnson. These companies are actively involved in the development of cancer vaccines and are working to bring new treatments to the market. Show Less Read more
